![](/img/cover-not-exists.png)
Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
Cohen, Jeffrey A, Comi, Giancarlo, Arnold, Douglas L, Bar-Or, Amit, Selmaj, Krzysztof W, Steinman, Lawrence, Havrdová, Eva K, Cree, Bruce AC, Montalbán, Xavier, Hartung, Hans-Peter, Huang, Vivian, FroLanguage:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458518789884
Date:
July, 2018
File:
PDF, 989 KB
english, 2018